Overview

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
A study comparing the topical application of Aczone® plus Differin® versus Duac® plus Differin® in patients with severe facial acne (facial acne vulgaris).
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Adapalene
Benzoyl Peroxide
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Dapsone